
3 Reasons Why Test-to-Treat is the Way of the Future
The next generation of test-to-treat diagnostics is here, and we’re on a mission to make healthcare accessible to all.
The next generation of test-to-treat diagnostics is here, and we’re on a mission to make healthcare accessible to all.
As of January 15, private insurance companies are required to reimburse members for at-home COVID-19 test purchases. Read and learn how to obtain your reimbursement.
Confused on the differences between COVID-19 tests? In this blog, we’re covering everything you need to know about diagnostic tests, antigen tests, and antibody tests.
Call our customer support team directly at 1-888-582-4724 or
This home test kit has not been FDA cleared or approved. This home test kit has been authorized by FDA under EUA. This home test kit has been authorized only for the testing of nasal swabs for detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This home test kit is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of IVDs for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or revoked sooner.
Ces autotests ont été autorisés par Santé Canada en vertu d'une autorisation d'arrêté provisoire. Le test Lucira COVID-19 & Grippe a été autorisé uniquement pour le test d'écouvillons nasaux d'individus symptomatiques pour la détection de l'acide nucléique du SRAS-CoV-2, de la grippe A et de la grippe B, et non pour d'autres virus ou agents pathogènes. Le test Lucira COVID-19 a été autorisé pour tester les prélèvements nasaux d'individus présentant ou non des symptômes pour la détection de l'acide nucléique du SRAS-CoV-2, et non pour d'autres virus ou agents pathogènes.
Pour demander plus d'informations nous contacter ou appelez le service client au 1-888-582-4724
Monday -Friday 7:00am-5:00pm PT
Pour les demandes générales des médias, veuillez contacter Lucira@luckybreakpr.com. If your media request is urgent, please contact: media@lucirahealth.com
© 2023 Lucira Health, Inc. All rights reserved.